Skip to main content
SpringerLink
Log in

Therapeutic aspects of prostaglandins in the treatment of peptic ulcer disease

  • Prostaglandins in the Upper Gastrointestinal Tract: Focus on Misoprostol
  • Prostaglandins in Peptic Ulcer Disease
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Studies of antisecretory compounds such as the H2-receptor antagonists have altered therapy and enhanced the understanding of peptic ulcer disease (PUD). While it is agreed that the dictum “no acid, no ulcer” is valid, acid hypersecretion does not appear to be the major determinant in a significant number of ulcer patients. More careful consideration of mucosal integrity in the pathogenesis of PUD is therefore necessary. A small but significant number of patients (5–15%) do not heal, despite the use of effective antiulcer drugs. Moreover, the posthealing recurrence rate may reach 75% after treatment is discontinued, and nearly one third of cigarette-smoking patients on maintenance therapy may suffer recurrences. Prostaglandins (PGs) are particularly important as potent antisecretory and effective antiulcer agents. In addition, recognition of their cytoprotective effects has stimulated research into the understanding and importance of mucosal protection and mucosal defense mechanisms. Animal studies show that PGs at nonantisecretory dosages prevent the development of gastric ulcers caused by virtually any insult. In humans, PGs prevent the mucosal damage caused by aspirin and ethanol. In some studies, the maintenance of normal mucosal integrity has been linked to normal mucosal production of PGs. Therefore, it is possible that exogenous PGs may be effective in patients whose ulcers do not heal with conventional therapy. They may reduce the recurrence of ulcers, particularly in those patients whose defect in mucosal integrity appars to be the major problem. Furthermore, in those patients subjected to the toxic effects of alcohol ingestion, nonsteroidal antiinflammatory drugs, antineoplastic drugs, and stress, exogenous PGs may prevent mucosal lesions. As such, PGs could be the ideal antiulcer drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Peterson WL, Sturdevant RAL, Frankl HD, Richardson CT, Isenberg JI, Elashoff JD, Jones JQ, Gross RA, McCallum RW, Fordtran JS: Healing of duodenal ulcer with antacid regimen. N Engl J Med 297:341–345, 1977

    Google Scholar 

  2. Berstad A, Rydning A, Aadland E, Kolstad B, Frislid K, Aaseth J: Controlled clinical trial of duodenal ulcer healing with antacid tablets. Scand J Gastroenterol 17:953–959, 1982

    Google Scholar 

  3. Robert A, Nezamis JE, Phillips JP: Inhibition of gastric secretion by prostaglandins. Am J Dig Dis 12:1073–1076, 1967

    Google Scholar 

  4. Wilson DE, Phillips C, Levine RA: Inhibition of gastric secretion in man by prostaglandin A1. Gastroenterology 61:201–206, 1971

    Google Scholar 

  5. Classen M, Koch H, Deyhle P, Weidenhiller S, Demling L: Wirkung von prostaglandin E1 auf die basale magensekretion des menschen. Klin Wochenschr 48:876–878, 1970

    Google Scholar 

  6. Robert A, Magerlein BJ: 15-methyl PGE2 and 16,16-dimethyl PGE2: Potent inhibitors of gastric secretion. Adv Biosci 9:247–253, 1973

    Google Scholar 

  7. Robert A, Nylander B, Andersson S: Marked inhibition of gastric secretion by two prostaglandin analogues given orally to man. Life Sci 14:533–538, 1974

    Google Scholar 

  8. Wilson DE, Winnan G, Quertermus J, Tao P: Effects of an orally administered prostaglandin analogue (16,16-dimethyl prostaglandin E2) on human gastric secretion. Gastroenterology 69:607–611, 1975

    Google Scholar 

  9. Wilson DE, Scruggs W, Birnbaum J: A new prostaglandin E1 analogue (CL-115,574) II. Effects on gastric acid secretion in the dog. Prostaglandins 22:970–978, 1981

    Google Scholar 

  10. Fung WP, Karium SMM, Tyc CY: Effect of 15(R), 15-methyl PGE2 on the healing of gastric ulcers. Med J Aust 2:127–128, 1976

    Google Scholar 

  11. Gibinski K, Rybicka J, Mikos E, Nowak A: Double-blind clinical trial on gastroduodenal ulcer healing with prostaglandin E2 analogues. Gut 18:636–639, 1977

    Google Scholar 

  12. Vantrappen G, Janssens J, Popiela T, Kulig J, Tytgat GNJ, Huibregtse K, Lambert R, Pauchard JP, Robert A: Effect of 15(R), 15-methyl prostaglandin E2 (arboprostil) on the healing of duodenal ulcer. A double-blind multicenter study. Gastroenterology 83:357–363, 1982

    Google Scholar 

  13. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433–443, 1979

    Google Scholar 

  14. Ito S, Lacy ER: Morphology of rat gastric mucosal damage, defense and restitution in the presence of luminal ethanol. Gastroenterology 88:250–260, 1985

    Google Scholar 

  15. Tarnawski A, Hollander D, Stachura J, Krause WJ, Gergely H: Prostaglandin protection of the gastric mucosa against alcohol injury: A dynamic time-related process. Gastroenterology 88:334–352, 1985

    Google Scholar 

  16. Minuz P, Cavallini G, Angelini GP, Lechi A, Brocco G, Riela A, Scuro LA, Velo GP: Carbenoxolone and prostaglandin E2 and F2α gastric juice levels in man. Pharmacol Res Commun 16:875–884, 1984

    Google Scholar 

  17. Hollander D, Tarnawski A, Gergely M, Zipser RD: Sucralfate protection of the gastric mucosa against ethanol induced injury: A prostaglandin mediated process? Scand J Gastroenterol 19(Suppl 101):97–102, 1984

    Google Scholar 

  18. Quadros E, Ramsamooj E, Wilson DE: Relationship between sucralfate, gastric cytoprotection and prostaglandin and mucus synthesis and secretion. Gastroenterology 88:1548, 1985 (abstract)

    Google Scholar 

  19. Dajani EZ, Callison DA, Bertermann RE: Effects of E-prostaglandins on canine gastric potential difference. Dig Dis Sci 23:436–442, 1978

    Google Scholar 

  20. Chaudhury TK, Jacobson ED: Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74:59–63, 1978

    Google Scholar 

  21. Robert A, Lancaster C, Davis JP, Field SO, Wickvima Sinha AJ, Thornburgh BA: Cytoprotection by prostaglandin occurs in spite of penetration of absolute ethanol into the gastric mucosa. Gastroenterology 88(1):328–333, 1985

    Google Scholar 

  22. Takeuchi K, Magee D, Critchlow J, Matthews J, Silen W: Studies of the pH gradient and thickness of frog gastric mucus gel. Gastroenterology 84:331–340, 1983

    Google Scholar 

  23. McQueen S, Allen A, Garner A: Measurement of gastric and duodenal mucus gel thickness.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. A Allen, G Flemstrom, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 215–221

    Google Scholar 

  24. Kivilaakso E, Flemstrom G: Surface pH gradient and prostaglandin cytoprotection in gastroduodenal mucosa.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. A Allen, G Flemstrom, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 227–232

    Google Scholar 

  25. Garner A, Heylings JR: Stimulation of alkaline secretion in amphibian-isolated gastric mucosa by 16,16-dimethyl PGE2 and PGF2α. Gastroenterology 76:497–503, 1979

    Google Scholar 

  26. Bolton JP, Palmer D, Cohen MM: Stimulation of mucus and nonparietal cell secretion by the E2 prostaglandins. Am J Dig Dis 23:359–364, 1978

    Google Scholar 

  27. Isenberg JI, Smedford B, Johansson C: Effect of graded doses of intraluminal H+, prostaglandin E2, and inhibition of endogenous prostaglandin synthesis on proximal duodenal bicarbonate secretion in unanesthetized rat. Gastroenterology 88:303–307, 1985

    Google Scholar 

  28. Hogan DL, Koss MA, Isenberg JI: Human proximal versus distal duodenal bicarbonate secretion: Effect of endogenous prostaglandin synthesis. Gastroenterology 88:1580, 1985 (abstract)

    Google Scholar 

  29. Kaymakcalan H, Ramsamooj E, Wilson DE: The effect of a novel prostaglandin (PG)E1 analogue (CL 115,574) on gastric acid and mucus secretion in man. Prostaglandins 28:5–12, 1984

    Google Scholar 

  30. Tao P, Wilson DE: Effects of prostaglandin E2, 16,16-dimethyl prostaglandin E2 and a prostaglandin endoperoxide analogue (U-46619) on gastric secretory volume [H+] and mucus synthesis and secretion in the rat. Prostaglandins 28:353–366, 1984

    Google Scholar 

  31. Menguy R, Masters YF: Effects of aspirin on gastric mucus secretion. Surg Gynecol Obstet 120:92–98, 1965

    Google Scholar 

  32. Menguy R, Desbaillets L: Influence of phenylbutazone on gastric secretion of mucus. Proc Soc Exp Biol Med 125:1108–1111, 1967

    Google Scholar 

  33. Whittle BJR, Kauffman GL, Moncada S: Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Nature 292:472–474, 1981

    Google Scholar 

  34. Whittle BJR: Cellular mediators in gastric damage: actions of thromboxane A2 and its inhibitors.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. A Allen, G Flemstrom, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 295–301

    Google Scholar 

  35. Leung FW, Itoh M, Hirabayashi K, Guth PH: Role of blood flow in gastric and duodenal mucosal injury in the rat. Gastroenterology 88(1):281–289, 1985

    Google Scholar 

  36. Szabo S, Trier JS, Brown A, Schnoor J: Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 88(1):228–236, 1985

    Google Scholar 

  37. Lacy ER, Ito S: Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology 82:619–625, 1982

    Google Scholar 

  38. Bardhan KD: Refractory duodenal ulcer. Gut 25:711–717, 1984

    Google Scholar 

  39. Sontag S, Graham DY, Belsito A, Weiss J, Farley A, Grunt R, Cohen N, Kinnear D, Davis W, Archambault A, Achord J, Thayer W, Gillies R, Sidorov J, Sabesin SM, Dyck W, Fleshler B, Cleator I, Wenger J, Opekun A: Cimetidine, cigarette smoking and recurrence of duodenal ulcer. N Engl J Med 311:689–693, 1984

    Google Scholar 

  40. Lam SK, Lau WY, Choi TK, Lai CL, Lok ASF, Hui WM, Ng MMT, Choi SKY: Prostaglandin E1 (misoprostol) over-comes the adverse effect of chronic cigarette smoking on duodenal ulcer healing. Dig Dis Sci 31(Suppl):68S-74S, 1986

    Google Scholar 

  41. Quimby GF, Avunduk Bonnice C, Burstein SH, Eastwood GL: Active smoking depresses prostaglandin synthesis in human gastroduodenal mucosa. Gastroenterology 88:1548, 1985 (abstract)

    Google Scholar 

  42. Johansson C, Kollberg B, Nordemar R, Samuelson K, Bergstrom S: Protective effect of prostaglandin E2 in the gastrointestinal tract during indomethacin treatment of rheumatic disease. Gastroenterology 78:479–483, 1980

    Google Scholar 

  43. Cohen MM: Use of prostaglandins to reduce gastroduodenal injury with nonsteroidal antiinflammatory drugs. Int Med Spec 5:75–87, 1984

    Google Scholar 

  44. Tarnawski A, Stachura J, Ivey KJ, Mach T, Klimczyk B, Bogdal J: Protection by prostaglandin against ethanol induced gastric mucosal damage in man. An endoscopic and histologic assessment. Gastroenterology 80:1300, 1981 (abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Downstate Medical Center, Sate University of New York, 450 Clarkson Avenue, 11203, Brooklyn, New York

    Donald E. Wilson MD

Authors
  1. Donald E. Wilson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, D.E. Therapeutic aspects of prostaglandins in the treatment of peptic ulcer disease. Digest Dis Sci 31 (Suppl 2), 42S–46S (1986). https://doi.org/10.1007/BF01309322

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01309322

Keywords

Search

Navigation